Next-generation sequencing analysis of IRS661-treated and ODN control-treated mouse macrophages in the in-vitro coinfection model of influenza A and Staphylococcus aureus
To investigate the effect of TLR7 antagonists IRS661 on the antibacterial and antiviral functions of mouse macrophages in vitro co-infection models of influenza and Staphylococcus aureus, we designed RNA-Seq analysis of macrophages in both the IRS661 treatment group and the control group.